The drug being tested in this study is called BLB-750 that is a vaccine for influenza infection. This study will look at immunogenicity and safety of two intramuscular vaccinations with BLB-750 at 3-week intervals in healthy Japanese adults. The study will enroll 55 participants. BLB-750 will be administered in opened manner: